Tomotsugu Seki
Overview
Explore the profile of Tomotsugu Seki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukui K, Koide M, Takamatsu K, Sugimoto H, Takeda Y, Akabame S, et al.
Circ J
. 2025 Jan;
89(3):303-311.
PMID: 39842801
Background: The clinical outcomes of percutaneous coronary intervention (PCI) using drug-coated balloons (DCB) for de novo coronary artery lesions with eruptive calcified nodules remain unclear. Methods And Results: This retrospective...
2.
Ozawa T, Yanishi K, Fujioka A, Seki T, Zen K, Matoba S
Eur J Vasc Endovasc Surg
. 2024 Sep;
68(6):748-756.
PMID: 39218296
Objective: The recommended revascularisation methods for acute limb ischaemia (ALI), which is caused by embolism and atherosclerotic thrombosis, include endovascular therapy (EVT) and open surgical revascularisation (OSR); however, treatment choices...
3.
Goto D, Yanishi K, Ozawa T, Yoshimura J, Kawamata H, Fujioka A, et al.
J Am Heart Assoc
. 2024 Jun;
13(12):e035017.
PMID: 38879458
Background: Acute mesenteric ischemia is rare, and few large-scale trials have evaluated endovascular therapy (EVT) and open surgical revascularization (OS). This study aimed to assess clinical outcomes after EVT or...
4.
Sakoda K, Mizuno K, Seki T, Shinkawa K, Kawai Y, Hayashi A, et al.
Ann Clin Epidemiol
. 2024 Apr;
6(2):33-41.
PMID: 38606040
Background: In real-world clinical practice, treatments selected for patients with autosomal dominant polycystic kidney disease (ADPKD) in the chronic kidney disease (CKD) without kidney replacement therapy (KRT) have not been...
5.
Seki T, Aki M, Furukawa T, Kawashima H, Miki T, Sawaki Y, et al.
J Med Internet Res
. 2024 Jan;
26:e55805.
PMID: 38170973
[This corrects the article DOI: 10.2196/40595.].
6.
Kagawa T, Kurahashi K, Seki T, Kawasaki Y, Nahara I, Takeda C, et al.
J Anesth
. 2023 Dec;
38(1):92-97.
PMID: 38102529
Purpose: Various basic and clinical studies have investigated the association between the types of anesthetic agents and prognosis. However, the results have varied among studies and remain controversial. In the...
7.
Nishi M, Shikuma A, Seki T, Horiguchi G, Matoba S
Epidemiol Psychiatr Sci
. 2023 Oct;
32:e62.
PMID: 37849318
Aims: Schizophrenia is associated with cardiovascular disease (CVD) risk, and patients with schizophrenia are more likely to receive suboptimal care for CVD. However, there is limited knowledge regarding in-hospital prognosis...
8.
Hirao Y, Seki T, Watanabe N, Matoba S
Can J Cardiol
. 2023 Jul;
39(11):1539-1548.
PMID: 37422259
Background: There has been no meta-analysis of whether percutaneous coronary intervention (PCI) with optimal medical therapy (OMT) improves health-related quality of life (HRQL) compared with OMT alone in patients with...
9.
Miyake K, Yoshida S, Seki T, Joo W, Takeuchi M, Kawakami K
J Anesth
. 2023 May;
37(4):562-572.
PMID: 37258777
Purpose: Nicorandil is occasionally administered to prevent myocardial ischemia during the perioperative period in patients with ischemic heart disease (IHD); however, its effectiveness has not been clarified. In this study,...
10.
Nishi M, Seki T, Shikuma A, Kawamata H, Horiguchi G, Matoba S
ESC Heart Fail
. 2023 Apr;
10(4):2262-2268.
PMID: 37075756
Aims: The impact of hospital volume on clinical performance has been investigated by many researchers to date and thought that it is associated with quality of care and outcome for...